Literature DB >> 10969802

Delineation of the 6p22 amplification unit in urinary bladder carcinoma cell lines.

J Bruch1, W A Schulz, J Häussler, I Melzner, S Brüderlein, P Möller, R Kemmerling, W Vogel, H Hameister.   

Abstract

Eight cell lines from transitional cell carcinoma of the urinary bladder were analyzed by comparative genomic hybridization. All tumor lines exhibited frequent chromosome gains (11.5/cell line) and losses (8.4/cell line). In six cell lines, gain of chromosome 5p was associated with gains of 6p and 20q. In five of these cell lines, amplification of parts of 6p was observed. Cytogenetic investigation combined with fluorescence in situ hybridization analysis revealed typical marker chromosomes with homogeneously staining regions (HSRs) containing material from 6p. By hybridizing individual yeast artificial chromosome probes from a chromosome 6p contig to these HSRs, a contig of three yeast artificial chromosomes common to all 6p HSRs was identified that spans less than 2 Mb. The genes SOX4 and PRL were shown to map to this region and to be coamplified in the cell lines. However, SOX4 was not overexpressed in any cell line and PRL was not expressed at all. Thus, the presumptive 6p oncogene remains to be conclusively identified.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10969802

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  16 in total

Review 1.  Chromosome 6p amplification and cancer progression.

Authors:  Gda C Santos; M Zielenska; M Prasad; J A Squire
Journal:  J Clin Pathol       Date:  2006-06-21       Impact factor: 3.411

2.  Inactivation of the Rb pathway and overexpression of both isoforms of E2F3 are obligate events in bladder tumours with 6p22 amplification.

Authors:  C D Hurst; D C Tomlinson; S V Williams; F M Platt; M A Knowles
Journal:  Oncogene       Date:  2007-11-26       Impact factor: 9.867

3.  Genomic characterization of three urinary bladder cancer cell lines: understanding genomic types of urinary bladder cancer.

Authors:  Rosário Pinto-Leite; Isabel Carreira; Joana Melo; Susana Isabel Ferreira; Ilda Ribeiro; Jaqueline Ferreira; Marco Filipe; Carina Bernardo; Regina Arantes-Rodrigues; Paula Oliveira; Lúcio Santos
Journal:  Tumour Biol       Date:  2014-01-24

4.  LOH at 6p21.3 region and HLA class I altered phenotypes in bladder carcinomas.

Authors:  Isabel Maleno; Jose Maria Romero; Teresa Cabrera; Laura Paco; Natalia Aptsiauri; Jose Manuel Cozar; Miguel Tallada; Miguel Angel López-Nevot; Federico Garrido
Journal:  Immunogenetics       Date:  2006-05-17       Impact factor: 2.846

5.  Cell cycle regulator gene CDC5L, a potential target for 6p12-p21 amplicon in osteosarcoma.

Authors:  Xin-Yan Lu; Yaojuan Lu; Yi-Jue Zhao; Kim Jaeweon; Jason Kang; Li Xiao-Nan; Gouqing Ge; Rene Meyer; Laszlo Perlaky; John Hicks; Murali Chintagumpala; Wei-Wen Cai; Marc Ladanyi; Richard Gorlick; Ching C Lau; Debananda Pati; Michael Sheldon; Pulivarthi H Rao
Journal:  Mol Cancer Res       Date:  2008-06       Impact factor: 5.852

6.  Whole-genome sequencing identifies genomic heterogeneity at a nucleotide and chromosomal level in bladder cancer.

Authors:  Carl D Morrison; Pengyuan Liu; Anna Woloszynska-Read; Jianmin Zhang; Wei Luo; Maochun Qin; Wiam Bshara; Jeffrey M Conroy; Linda Sabatini; Peter Vedell; Donghai Xiong; Song Liu; Jianmin Wang; He Shen; Yinwei Li; Angela R Omilian; Annette Hill; Karen Head; Khurshid Guru; Dimiter Kunnev; Robert Leach; Kevin H Eng; Christopher Darlak; Christopher Hoeflich; Srividya Veeranki; Sean Glenn; Ming You; Steven C Pruitt; Candace S Johnson; Donald L Trump
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-27       Impact factor: 11.205

7.  Hypermethylation of miR-203 in endometrial carcinomas.

Authors:  Yi-Wen Huang; Chieh-Ti Kuo; Jo-Hsin Chen; Paul J Goodfellow; Tim H-M Huang; Janet S Rader; Denise S Uyar
Journal:  Gynecol Oncol       Date:  2014-02-14       Impact factor: 5.482

8.  Defining a 0.5-mb region of genomic gain on chromosome 6p22 in bladder cancer by quantitative-multiplex polymerase chain reaction.

Authors:  Andrew J Evans; Brenda L Gallie; Michael A S Jewett; Gregory R Pond; Kirk Vandezande; John Underwood; Yves Fradet; Gloria Lim; Paula Marrano; Maria Zielenska; Jeremy A Squire
Journal:  Am J Pathol       Date:  2004-01       Impact factor: 4.307

9.  KIF14 and E2F3 mRNA expression in human retinoblastoma and its phenotype association.

Authors:  Jagadeesan Madhavan; Moutushy Mitra; Kandalam Mallikarjuna; Oberoi Pranav; Ramalingam Srinivasan; Amit Nagpal; Perumal Venkatesan; Govindasamy Kumaramanickavel
Journal:  Mol Vis       Date:  2009-01-26       Impact factor: 2.367

10.  Tiling resolution array CGH and high density expression profiling of urothelial carcinomas delineate genomic amplicons and candidate target genes specific for advanced tumors.

Authors:  Markus Heidenblad; David Lindgren; Tord Jonson; Fredrik Liedberg; Srinivas Veerla; Gunilla Chebil; Sigurdur Gudjonsson; Ake Borg; Wiking Månsson; Mattias Höglund
Journal:  BMC Med Genomics       Date:  2008-01-31       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.